HSP90AB1 and cancer: Aha1 and Cdc37 are overexpressed in cancer and can be post-translationally modified by Hsp90 client enzymes, generating reciprocal regulatory mechanisms of the chaperone machinery: In this context, pharmacological inhibition of clients or downregulation of cochaperone levels hypersensitize cancer cells to Hsp90 inhibitors.